PBD News and Press, Invesco Global Clean Energy From 02/28/21

Often, the action in a stock is based on investors perceptions, but it can be a circular event.  Not only is the price action representative of perception, but it can influence perception too.  In the case of Invesco Global Clean Energ (NYSE: PBD) we can see this in the charts...

The electrification of transportation and other ongoing initiatives by major industries that are pursuing de-carbonization are driving the clean energy industry’s growth. The new U.S. Presidential administration is also facilitating the deployment of renewables across sectors to curb c...

Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Positive Topline Results from BRIGHT Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa 2 mg/kg every Four Weeks for Treatment of Fabry Disease Study achieved key objectives for safet...

Investors in Invesco Global Clean Energ (NYSE: PBD) like to make good decisions, that means they like to buy and sell at the right times, and to do that the best tools involve charts, pivot points, and the technical data.  Below, we have provided a snapshot for PBD that reveal...

The Invesco Global Clean Energy ETF seeks to track the performance of the WilderHill New Energy Global Innovation Index ("Underlying Index"). The Fund has a total AUM of ~$487mn with an expense ratio of 0.75%, which is on the higher side when compared with its peers. PBD stands to...

Protalix BioTherapeutics Completes Raise of Approximately $40 Million in Gross Proceeds Anticipated PDUFA for PRX-102 in Fabry disease currently set for April 27, 2021 Company, with its Commercialization Partner, Chiesi, poised to commercialize PRX-102 Additional data an...

Green energy is the hot space to be in and STPK has a proprietary platform that could be a game changer for utilities, large corporations and the entire energy grid. STEM Inc.'s revenue growth is explosive, as over the next five years, it’s projected to increase by 2,760.61% to...

Despite questions over financing the European Union's new Green Deal, the green transition is now underway. The European Green Deal is the centrepiece of the EU's climate strategy. More investors are seeking to address climate change within their fixed income portfolios. For...

Protalix BioTherapeutics Announces Pricing of its Upsized Public Offering of Common Stock PR Newswire CARMIEL, Israel , Feb. 11, 2021 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX, TASE: PLX) (the "Company"), a biopharmaceutical company focus...

Protalix BioTherapeutics Announces Proposed Public Offering of Common Stock PR Newswire CARMIEL, Israel , Feb. 11, 2021 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, produc...